Freitag Gregory Gene has filed 19 insider transactions across 3 companies since May 2023.
Most recent transaction: a grant/award of 54876 shares of PDS Biotechnology Corp ($PDSB) on January 12, 2026.
Activity breakdown: 2 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | PDS Biotechnology Corp | $PDSB | Freitag Gregory Gene | Not found | A | Employee Stock Option (Right to Buy) | 54876 | $0.00 | 54,876.0000 | 48,980,307 | 9999.99% | 0.11% |
| July 11, 2025 | ZyVersa Therapeutics, Inc. | $ZVSA | Freitag Gregory Gene | Director | A | Stock Options | 11066 | $0.00 | 11,066.0000 | 2,568,191 | 9999.99% | 0.43% |
| June 11, 2025 | PDS Biotechnology Corp | $PDSB | Freitag Gregory Gene | Not found | A | Employee Stock Option (Right to Buy) | 22700 | $0.00 | 22,700.0000 | 45,395,851 | 9999.99% | 0.05% |
| Feb. 28, 2025 | PDS Biotechnology Corp | $PDSB | Freitag Gregory Gene | Not found | P | Common Warrant | 15060 | $0.00 | 15,060.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2025 | PDS Biotechnology Corp | $PDSB | Freitag Gregory Gene | Not found | P | Common Stock | 15060 | $1.66 | 61,213.0000 | 0 | 32.63% | 0.00% |
| May 24, 2023 | ZyVersa Therapeutics, Inc. | $ZVSA | Freitag Gregory Gene | Director | A | Stock Options | 132 | $0.00 | 132.0000 | 0 | 9999.99% | 0.00% |
| June 24, 2024 | PDS Biotechnology Corp | $PDSB | Freitag Gregory Gene | Not found | A | Employee Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | M | Common Stock | 11904 | $0.00 | 283,498.0000 | 42,878,543 | 4.38% | 0.03% |
| June 4, 2024 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| March 7, 2024 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | S | Common Stock | 25000 | $9.00 | 271,594.0000 | 42,878,543 | 8.43% | 0.06% |
| Sept. 1, 2023 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | A | Restricted Stock Units | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| Sept. 1, 2023 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | A | Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| July 14, 2023 | PDS Biotechnology Corp | $PDSB | Freitag Gregory Gene | Not found | A | Employee Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | S | Common Stock | 12500 | $8.65 | 319,615.0000 | 42,083,125 | 3.76% | 0.03% |
| June 1, 2023 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | M | Restricted Stock Units | 6459 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.02% |
| June 1, 2023 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | S | Common Stock | 29480 | $8.74 | 290,135.0000 | 42,083,125 | 9.22% | 0.07% |
| June 1, 2023 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | M | Common Stock | 6459 | $0.00 | 296,594.0000 | 42,083,125 | 2.23% | 0.02% |
| May 23, 2023 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | S | Common Stock | 2828 | $9.17 | 336,755.0000 | 42,083,125 | 0.83% | 0.01% |
| May 23, 2023 | Axogen, Inc. | $AXGN | Freitag Gregory Gene | Director | S | Common Stock | 4640 | $9.26 | 332,115.0000 | 42,083,125 | 1.38% | 0.01% |